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Background
Following the initial outbreak of Severe Acute Respiratory Syndrome (SARS) in 
2003, extensive research centered around the molecular mechanisms, 
pathophysiology, and treatment for the coronavirus family. Here, we describe 
the pathophysiology of SARS-CoV2, detection tools including RT-PCR and rapid 
antigen testing, treatments, and vaccines approved for Coronavirus infectious 
disease 2019 (Covid-19) .
Purpose
Our presentation highlights the role of pharmacists in the COVID-19 pandemic 
in terms of drug treatment, consultation, and vaccination.
Method
Covid-19 related keyword search and review of primary and tertiary literatures 
available in medRxiv and PubMed. The search focused on COVID-19 
pathophysiology, clinical data, detection, treatments, and available vaccines 






• Israel has become a successful country in terms of  Covid-19 prophylaxis by providing vaccines to 95% of the population. 
An abundance of front-line healthcare workers emerged to administer millions of vaccine to patients, minimizing the 
mortality rate of COVID-19 significantly according. Still, there are upcoming vaccines with different types of technologies 
as displayed on the table below. 
Summary
• RT-PCR, LAMP-PCR, and ELISA are all available for COVID-19 detection 
and offer precision and accuracy. Antigen testing is done using CRISPR-
cas9 technology that employs gene editing processes. However, the 
process requires high technical training along with laboratory 
equipped with a sophisticated setup.
• From the pharmacist’s perspective, Tocilizumab and Remdesevir stand 
out as emergency  treatments for hospital-admitted patients  to 
reduce the mortality rate, and duration of the hospital stays in ICU set-
up in severe COVID-19 cases. 
• COVID-19  vaccines have been developed for prophylaxis against 
infection by targeting the S-protein. With the Emergency Use 
Authorization and release of Covid-19 vaccines, pharmacists will 
continue to provide the immunizations, monitor the side effects, 
engage in patient education and counseling to improve immunization 
rates, and ultimately help reduce the rates of infection in 
communities.
Discussion 
• Deaths due to COVID-19, as well as the number of new positive cases 
increased almost daily earlier in 2020.  This led to a burden on world-
wide healthcare institutions, leaving many hospitals without available 
patient beds.
• Community pharmacist’s role in COVID-19 test and vaccine 
administration is crucial. In addition, community pharmacists could 
engage in counseling patients via telehealth regarding treatment 
options, quarantining, COVID-19 test results, or vaccination.
• Hospital pharmacists on the other hand would handle the temporary 
protocols for the antiviral or monoclonal antibody treatments for 
severe COVID-19 hospitalized cases. 
• Counseling points and treatment evaluation from pharmacists would 
be critical in terms of administering COVID-19 vaccines and 
medications. It is expected that Pharmacist’s expertise along with 
other frontline healthcare workers would be in high demanded during 
the pandemic  in order to control  infection rates, reduce the mortality 
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Covid-19 Treatment Options Role of Pharmacists
Monoclonal Antibody: 
Tocilizumab
Tocilizumab blocks the IL-6 
receptor to reduce the 
inflammatory response.
Block the spike protein of 
coronaviruses from entering 
ACE receptor on host cells.6,7,8
Tocilizumab can be used to 
treat the severe COVID-19 -
cytokine release which leads 
to inflammatory responses on 
the lungs.11
Increase oxygen saturation.
Our review highlights this drug 
because of its well-tolerated 
properties, and less side 
effects compared to other 
monoclonal antibody drugs 
like Gimsilumab.
Retroviral Therapy: Remdesivir
Reduction in SARS-CoV 
replication
Remdesivir has been shown to 
reduce both hospital stays, 
and mortality rates associated 
with Covid-19.
Testing Utilization
RNA detection via Real-Time (RT)-PCR •Conventional method used to detect Covid-19
•Early disease diagnosis and contact tracing. 2,3
ELISA
Antibody detection-7 days after exposure
Rapid Antigen Testing Convenient, fast result
CRISPR-Cas 9
Fast and accurate testing method
SARS Infection Physiology
SARS 2003









droplets leads to infection
Via binding to ACE-2 
receptors
Virus exits the cells via 
lysosome
Inflammatory mediators
Vaccine Technology Number of doses
Pfizer/BioNTech mRNA 2
Moderna mRNA 2
Johnson & Johnson Viral Vector 1
Oxford/AstraZeneca Viral Vector 1
Novavax Protein Subunit Work in Progress
Sanofi Pasteur/G SK Protein Subunit Work in Progress
Medicago/G SK VLP+ adjuvant Work in Progress
